Q1 2023 Holdings
Filed 2023-05-15 | 58 holdings | $338.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Reata Pharmaceuticals Inc(RETAEUR)Call | CL A | 75615P103 | $27.3M | 300,000 | 8.1% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $22.9M | 300,000 | 6.8% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $17.2M | 125,000 | 5.1% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $16.5M | 1,100,000 | 4.9% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $13.9M | 475,000 | 4.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $13.9M | 225,000 | 4.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $11.8M | 110,000 | 3.5% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $10.9M | 164,620 | 3.2% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $10.5M | 275,000 | 3.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $10.0M | 600,000 | 3.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.4M | 225,000 | 2.5% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $8.4M | 2,000,000 | 2.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $8.3M | 60,000 | 2.4% |
| Pfizer Inc(PFE) | COM | 717081103 | $8.2M | 200,000 | 2.4% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $8.1M | 250,000 | 2.4% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $7.8M | 50,000 | 2.3% |
| Uniqure NV(QURE) | SHS | N90064101 | $7.6M | 375,000 | 2.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $7.3M | 30,000 | 2.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.2M | 200,000 | 2.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $6.9M | 325,000 | 2.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $6.4M | 70,000 | 1.9% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $6.1M | 1,000,000 | 1.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $6.0M | 450,000 | 1.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $5.9M | 550,000 | 1.8% |
| Incyte Corp(INCY) | COM | 45337C102 | $5.4M | 75,000 | 1.6% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $5.3M | 475,000 | 1.6% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $5.2M | 140,000 | 1.5% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $5.2M | 225,000 | 1.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $4.5M | 175,000 | 1.3% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $4.3M | 175,000 | 1.3% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $4.2M | 195,000 | 1.2% |
| Aerovate Therapeutics Inc | COM | 008064107 | $4.0M | 200,000 | 1.2% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $3.7M | 120,000 | 1.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.4M | 425,000 | 1.0% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $3.4M | 51,900 | 1.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $3.2M | 17,500 | 0.9% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $3.0M | 200,000 | 0.9% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $2.3M | 275,000 | 0.7% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $2.2M | 250,000 | 0.7% |
| Rain Oncology Inc | COM | 75082Q105 | $2.2M | 250,000 | 0.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $2.1M | 100,000 | 0.6% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $1.9M | 125,000 | 0.6% |
| Altimmune Inc(ALT)Call | COM NEW | 02155H200 | $1.7M | 400,000 | 0.5% |
| Prometheus Biosciences Inc | COM | 74349U108 | $1.6M | 15,000 | 0.5% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $1.5M | 200,000 | 0.5% |
| 89Bio Inc(ETNBGBP)Call | COM | 282559103 | $1.5M | 100,000 | 0.5% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $1.4M | 75,000 | 0.4% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $1.3M | 350,000 | 0.4% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $1.1M | 150,000 | 0.3% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $1.0M | 80,000 | 0.3% |